Does drospirenone (including drospirenone/ethinyl estradiol combination oral contraceptives) interact with lamotrigine?

Does Drospirenone Interact with Lamotrigine?

Yes, drospirenone-containing oral contraceptives significantly interact with lamotrigine by reducing lamotrigine serum concentrations by approximately 50%, which may lead to loss of seizure control. This interaction requires lamotrigine dose adjustments when starting or stopping these contraceptives.

The Mechanism and Clinical Impact

The interaction occurs through the ethinyl estradiol (EE) component of combined oral contraceptives (COCs), not drospirenone itself. COCs containing EE induce lamotrigine glucuronidation, significantly increasing lamotrigine clearance 1. The FDA drug label explicitly states: "COCs have been shown to significantly decrease plasma concentrations of lamotrigine, likely due to induction of lamotrigine glucuronidation. This may reduce seizure control; therefore, dosage adjustments of lamotrigine may be necessary" 1.

Key pharmacokinetic findings:

• Lamotrigine AUC decreases to approximately 48% of baseline when co-administered with COCs 2
• Lamotrigine Cmax decreases to approximately 61% of baseline 2
• This reduction is clinically significant and has resulted in increased seizure activity in some patients 3

Evidence Hierarchy

The 2010 U.S. Medical Eligibility Criteria assigns a Category 3 rating to lamotrigine when used with COCs, meaning "the theoretical or proven risks usually outweigh the advantages" 3. This guideline specifically notes that pharmacokinetic studies show lamotrigine levels decrease significantly during COC use, and some women experienced increased seizure activity 3.

Research confirms that ethinyl estradiol is the culprit, not progestins. A 2005 study demonstrated that EE-containing contraceptives reduced lamotrigine concentration-to-dose ratios from 0.017 to 0.010 (p=0.003), while progestogen-only contraceptives showed no significant effect (0.02 vs. 0.017, not significant) 4. A 2020 study further specified that drospirenone and levonorgestrel (when combined with EE) reduced lamotrigine levels, but gestoden did not 5.

Practical Management Algorithm

When starting drospirenone/EE in a patient on lamotrigine:

1. Anticipate a 50% reduction in lamotrigine serum levels
2. Consider increasing lamotrigine dose by up to 2-fold to maintain therapeutic levels
3. Monitor seizure control closely during the first 2-3 months
4. Check lamotrigine serum concentrations if available

When stopping drospirenone/EE in a patient on lamotrigine:

1. Expect lamotrigine levels to double within 2-6 months
2. Reduce lamotrigine dose by approximately 50% to avoid toxicity
3. Monitor for lamotrigine adverse effects (dizziness, diplopia, ataxia, rash)
4. Gradual dose adjustments are safer than abrupt changes

During the pill-free interval (inactive pills):

• Lamotrigine levels may fluctuate, with levels rising during the 4-7 day hormone-free interval 5
• This creates a risk of both breakthrough seizures (during active pills) and toxicity (during inactive pills)
• Extended or continuous COC regimens may provide more stable lamotrigine levels

The Reverse Interaction

Lamotrigine has minimal effect on contraceptive efficacy. While lamotrigine modestly reduces levonorgestrel levels by approximately 19% (AUC ratio 0.81) 2, this does not appear to compromise ovulation suppression. FSH and LH levels increase, but progesterone remains low, suggesting maintained contraceptive efficacy 2. The 2020 study found no difference in progestin concentrations between lamotrigine users and controls 5.

However, intermenstrual bleeding occurred in 32% of subjects during co-administration 2, which may affect adherence and patient satisfaction.

Critical Caveats

• The 2024 U.S. Selected Practice Recommendations maintains the Category 3 classification for lamotrigine with CHCs, but Category 1 (no restriction) for lamotrigine with progestin-only pills, implants, DMPA, and IUDs 6
• Progestin-only contraceptives (pills, implants, IUDs) do NOT interact with lamotrigine and are preferred alternatives 4
• The interaction applies to all EE-containing contraceptives, not just drospirenone formulations
• When COCs are chosen despite the interaction, use preparations containing minimum 30 μg EE per the 2010 guidelines 3

Alternative Contraceptive Options

For women on lamotrigine requiring contraception, consider:

1. Progestin-only pills (norethindrone or drospirenone-only formulations) - no interaction 6, 4
2. Levonorgestrel or copper IUDs - no interaction 6
3. Etonogestrel implant - no interaction 6
4. DMPA injection - no interaction 6

These alternatives avoid the lamotrigine interaction entirely while maintaining excellent contraceptive efficacy.